About Cellarcus Biosciences
Cellarcus Biosciences is a company based in San Diego (United States) founded in 2017.. Cellarcus Biosciences offers products and services including vFC™ Vesicle Analysis Assays, vTag™ Antibodies, Vesicles and Vesicle Assay Standards, and evCRO Vesicle Analysis Services. Cellarcus Biosciences operates in a competitive market with competitors including Alamar Biosciences, Glympse Bio, Harmonic Discovery, Seahorse Bioscience and Luceome Biotechnologies, among others.
- Headquarter San Diego, United States
-
Sectors
Healthcare
-
Email
***********
-
Phone
*********
-
Website
*********
- Legal Name Cellarcus Biosciences, Inc.
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Latest Funding Round
$2 M (USD), Grant
Jun 09, 2023
- Investors
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Cellarcus Biosciences
Cellarcus Biosciences offers a comprehensive portfolio of products and services, including vFC™ Vesicle Analysis Assays, vTag™ Antibodies, Vesicles and Vesicle Assay Standards, and evCRO Vesicle Analysis Services. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Assays for direct EV measurement in biofluids.
Antibodies for no-wash EV cargo quantitation.
Standards for accurate EV sizing and calibration.
Services for professional EV analysis support.
Funding Insights of Cellarcus Biosciences
- Total Funding Total Funding
- Total Rounds 4
- Last Round Grant — $2.0M
-
First Round
First Round
(01 Jul 2017)
- Investors Count 1
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jun, 2023 | Amount | Grant - Cellarcus Biosciences | Valuation |
investors |
|
| Aug, 2020 | Amount | Grant - Cellarcus Biosciences | Valuation |
investors |
|
| Apr, 2019 | Amount | Grant - Cellarcus Biosciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Cellarcus Biosciences
Cellarcus Biosciences has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include HHS. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Public health and human services are overseen by HHS.
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Cellarcus Biosciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Cellarcus Biosciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Cellarcus Biosciences Comparisons
Competitors of Cellarcus Biosciences
Cellarcus Biosciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Alamar Biosciences, Glympse Bio, Harmonic Discovery, Seahorse Bioscience and Luceome Biotechnologies, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Ultra-high sensitivity protein analysis solutions are provided across multiplex levels.
|
|
| domain | founded_year | HQ Location |
Multiple human diseases are monitored noninvasively through urine-based analysis.
|
|
| domain | founded_year | HQ Location |
Developer of kinase inhibitor drugs for oncology
|
|
| domain | founded_year | HQ Location |
Cellular metabolic status is measured via the Seahorse XFp Analyzer.
|
|
| domain | founded_year | HQ Location |
Assay technology is developed for identifying drugs against kinases.
|
|
| domain | founded_year | HQ Location |
Develops innovative in-vitro diagnostic platforms using optical interrogation of biochip-kits.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Frequently Asked Questions about Cellarcus Biosciences
When was Cellarcus Biosciences founded?
Cellarcus Biosciences was founded in 2017.
Where is Cellarcus Biosciences located?
Cellarcus Biosciences is headquartered in San Diego, United States. It is registered at San Diego, California, United States.
Who is the current CEO of Cellarcus Biosciences?
John Nolan is the current CEO of Cellarcus Biosciences.
What does Cellarcus Biosciences do?
Cellarcus Biosciences was founded in 2017 and is based in San Diego, United States. Operations are conducted in the biotechnology sector, where analysis of extracellular vesicles is performed in biofluids, culture supernatant, and isolated samples. The vFC assay is utilized for counting and sizing vesicles in media or buffers. Services target research and diagnostic applications in life sciences.
Who are the top competitors of Cellarcus Biosciences?
Cellarcus Biosciences's top competitors include Alamar Biosciences, Glympse Bio and Harmonic Discovery.
What products or services does Cellarcus Biosciences offer?
Cellarcus Biosciences offers vFC™ Vesicle Analysis Assays, vTag™ Antibodies, Vesicles and Vesicle Assay Standards, and evCRO Vesicle Analysis Services.
Who are Cellarcus Biosciences's investors?
Cellarcus Biosciences has 1 investor. Key investors include HHS.